RetiPharma IVS

CVR37134120Opløst

Core data

Name
RetiPharma IVS
Address
Ole Maaløes Vej 3, 2200, København N
Founded
Sep 10, 2015
3 / 2Jan 2020
Locations (P-units)
0
Branch
Anden teknisk rådgivning (711290)

Keep track of RetiPharma IVS

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account

Description

The companys primary activities is development and selling treatments for eye disease.

Financials

Company financials
Reporting period
2018DKKOpen PDF
Gross profit
-147,051
Operating profit
-158,357
Profit before tax
-264,288
Net income
-203,870
Total assets
6,582,356
Equity
-190,437
2017–2018

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

From cvr.dk

Company
2425****Show full

Founders

FounderRegistered as founderCurrent rolesOwnership
David Paul Drucker WoldbyeRegistered as founderSep 10, 2015Current roles
—
Ownership
—
Kristian KlempRegistered as founderSep 10, 2015Current roles
—
Ownership
—

People

No current people or role data available

Auditor

inforevision, Statsautoriseret RevisionsaktieselskabAuditorSten PedersenRoleStatsautoriseret revisorFromJun 3, 2019
—AuditorLasse SværkeRoleStatsautoriseret revisorFromJun 3, 2019
Ownership5–9.99 %Voting rights5 %FromApr 16, 2018ToSep 25, 2020
Ownership20–24.99 %Voting rights20 %FromOct 10, 2015ToSep 25, 2020
Ownership10–14.99 %Voting rights10 %FromOct 10, 2015ToSep 25, 2020
Ownership20–24.99 %Voting rights20 %FromOct 6, 2015ToSep 25, 2020
Ownership20–24.99 %Voting rights20 %FromOct 5, 2015ToSep 25, 2020
Ownership5–9.99 %Voting rights5 %FromOct 10, 2015ToApr 16, 2018

Official sources